oncliveMay 151 min read

Dr Hafron on the FDA Approval of Adjuvant Atezolizumab in MRD+ MIBC

Jason Hafron, MD, discusses the significance of the FDA approval of adjuvant atezolizumab for MRD+ muscle-invasive bladder cancer.

source

Reporting by onclive. The original article may no longer be reachable at its published URL.

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

oncliveMay 151 min read

Jason Hafron, MD, discusses the significance of the FDA approval of adjuvant atezolizumab for MRD+ muscle-invasive bladder cancer.

source

Reporting by onclive. The original article may no longer be reachable at its published URL.